The Weekly Litigation News Digest is now live. Subscribe now

High-Stability Packaged Solutions Of T4 Thyroid Hormone - EP3528847

The patent EP3528847 was granted to Altergon on Jul 22, 2020. The application was originally filed on Oct 17, 2017 under application number EP17794903A. The patent is currently recorded with a legal status of "Revoked".

EP3528847

ALTERGON
Application Number
EP17794903A
Filing Date
Oct 17, 2017
Status
Revoked
Mar 11, 2025
Publication Date
Jul 22, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

UNI PHARMA KLEON TSETIS PHARMACEUTICAL LABORATORIESApr 21, 2021SONNENHAUSERADMISSIBLE

Patent Citations (9) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO2010086030
DESCRIPTIONWO2013072304
INTERNATIONAL-SEARCH-REPORTUS9345772
INTERNATIONAL-SEARCH-REPORTWO2012120338
INTERNATIONAL-SEARCH-REPORTWO2013072304
OPPOSITIONEP2683361
OPPOSITIONWO2013072304
OPPOSITIONWO2016137969
OTHERWO2013072304

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents